Keyphrases
Affected children
33%
Angiogenesis Inducing Agents
33%
Antiangiogenesis Agents
33%
Basic Fibroblast Growth Factor (bFGF)
66%
Blood Vessel Formation
33%
Capillary Hemangioma
33%
Clinical Outcomes
33%
Corticosteroids
33%
Growth Factor Pathway
33%
Growth Velocity
100%
Head-and-neck
33%
Hemangioma
66%
Infantile Hemangioma
33%
Infection Risk
33%
Interferon-α (IFN-α)
33%
Intracranial Hemangioma
100%
Intracranial Lesions
33%
Involution
33%
Life-threatening
100%
Life-threatening Complications
33%
Local Control
33%
Mortality Rate
33%
Natural History
33%
New Blood Vessel
33%
Rapid Growth
33%
Surgical Intervention
33%
Thalidomide
100%
Therapeutic Potential
33%
Therapeutic Response
33%
Toxicity Profile
33%
Tumor
66%
Vascular Endothelial Growth Factor
66%
Vascular Tumor
33%
Medicine and Dentistry
Angiogenesis
33%
Angiogenesis Inhibitor
33%
Brain Hemangioma
100%
Capillary Hemangioma
66%
Fibroblast Growth Factor 2
66%
Growth Rate
100%
Hemangioma
66%
Interferon
33%
Involution
33%
Mortality Rate
33%
Neck
33%
Neoplasm
66%
Surgery
33%
Thalidomide
100%
Treatment Response
33%
Vascular Tissue Neoplasm
33%
Vasculotropin
66%
Pharmacology, Toxicology and Pharmaceutical Science
Angiogenesis Inhibitor
33%
Brain Hemangioma
100%
Capillary Hemangioma
66%
Fibroblast Growth Factor 2
66%
Hemangioma
66%
Interferon
33%
Mortality Rate
33%
Neoplasm
66%
Thalidomide
100%
Vascular Tumor
33%
Vasculotropin
66%